BCRX · Congress trades
See corporate insider trades for BCRX →
Trades by members of Congress
| Member | Party | Owner | Ticker | Asset | Type | Amount range | Traded | Disclosed | Delay | |
|---|---|---|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. Rep | D-CA | Self | BCRX | BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) | Purchase | $1.0K – $15.0K | 2026-07-10 | 2026-09-04 | 56d LATE | PDF↗ |
| Gilbert Ray Cisneros, Jr. Rep | D-CA | Self | BCRX | BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) | Purchase | $1.0K – $15.0K | 2025-11-13 | 2025-12-15 | 32d | PDF↗ |
| Josh Gottheimer Rep | D-NJ | Joint | BCRX | BioCryst Pharmaceuticals, Inc. (BCRX) | Purchase | $1.0K – $15.0K | 2023-10-16 | 2023-11-11 | 26d | PDF↗ |
| Josh Gottheimer Rep | D-NJ | Joint | BCRX | BioCryst Pharmaceuticals, Inc. (BCRX) | Sale | $1.0K – $15.0K | 2023-09-15 | 2023-10-15 | 30d | PDF↗ |
| Josh Gottheimer Rep | D-NJ | Joint | BCRX | BioCryst Pharmaceuticals, Inc. (BCRX) | Purchase | $1.0K – $15.0K | 2022-08-11 | 2022-09-16 | 36d | PDF↗ |
Public-interest transparency data from official U.S. House Clerk STOCK Act disclosures (periodic transaction reports). Amounts are disclosed as ranges (e.g. $1,001–$15,000), not exact values, and members may report a trade up to 45 days after it happens — so recent activity can be missing. Trades flagged LATE were reported after 45 days. Scanned paper filings are linked but not parsed. Senate eFD ingest is not available yet.